Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome

Lupus

Volumn 21, Issue 4, 2012, Pages 438-440

  Elazary, A Scheiman ^a   Klahr, P P ^b   Hershko, A Y ^c   Dranitzki, Z ^a   Rubinow, A ^a   Naparstek, Y ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

alveolar; antiphospholipid; diffuse; hemorrhage; rituximab

Indexed keywords

AZATHIOPRINE; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; PREDNISONE; RITUXIMAB;

ADULT; ANTIBODY TITER; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; DIFFUSE ALVEOLAR HEMORRHAGE; FOLLOW UP; HEMOPTYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG HEMORRHAGE; MALE; NEUTROPENIA; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BIOLOGICAL MARKERS; HEMORRHAGE; HUMANS; IMMUNOLOGIC FACTORS; LUNG DISEASES; MALE; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858658685     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311422713     Document Type: Article

References (9)

1. Deane KD, West SG. Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: A case report and literature review. Semin Arthritis Rheum. 2005 ; 35: 154-165 (Pubitemid 41713955)
2. Espinosa G, Cervera R, Font J, Asherson A. The lung in the antiphospholipid syndrome. Ann Rheum Dis. 2002 ; 61: 195-198 (Pubitemid 34177746)
3. Gertner E. Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment. J Rheumatol. 1999 ; 26: 805-807 (Pubitemid 29195666)
4. Asherson RA, Greenblatt MA. Recurrent alveolar hemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome. J Clin Rheumatol. 2001 ; 7: 30-33 (Pubitemid 32172765)
5. Erre GL, Pardini S, Faedda R, Passiu G. Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature. Lupus. 2008 ; 17: 50-55 (Pubitemid 351487020)
6. Trappe R, Loew A, Thuss-Patience P, Dörken B, Riess H. Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab-monitoring of antiphospholipid and anti-GP antibodies: a case report. Ann Hematol. 2006 ; 85: 134-135 (Pubitemid 43085311)
7. Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Aguirre C. Sustained response to rituximab of autoimmune haemolytic anaemia associated with antiphospholipid syndrome. Haematologica. 2004 ; 89: ECR34 - ECR34
8. Harner KC, Jackson LW, Drabick JJ. Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjögren's syndrome. Rheumatology (Oxford). 2004 ; 43: 1309-1310 (Pubitemid 39359313)
9. Pottier V, Pierrot M, Subra JF, et al. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage. Lupus. 2011 ; 20: 656-659